New Haven Pharmaceuticals, Inc.

Ohio State University has brought on a former biopharma executive to lead its cancer-specific Drug Development Institute with the goal of enhancing and optimizing promising oncology research for pot

IN VITRO DIAGNOSTICS Financings Vermillion Inc. Vermillion Inc. grossed $5.6mm through the private sale of 3.75mm common shares at $1.40 (a 6% premium). Investors also received five-year warrants

Orphan drugs were central to FDA’s busy week of approvals, as the agency cleared two novel agents and a new use for a blockbuster biologic for rare disease indications. Wellstat Files Second Indicatio

FDA's approvals in the past week included its first new molecular entity approval in the month of June, The Medicines Co. 's Kengreal. Two more NMEs have user fee goals coming up in early July. K